Research funded to develop plant-based diabetes treatment

BLACKSBURG, Va., July 9, 2001 Virginia Tech biochemistry and biology researchers are exploring whether plants can be engineered to produce a human enzyme to treat Type 2 diabetes. The research is being funded by a grant from Virginias Commonwealth Health Research Board (CHRB).

If Glenda Gillaspy's research leads in the direction she expects, plants will cheaply produce the human enzyme that is now painstakingly and expensively synthesized to treat 16 million Americans suffering from Type 2 diabetes, The CHRB has provided funding to Gillaspy, assistant professor of biochemistry, and collaborator Cynthia Gibas, assistant professor of biology, to lay the groundwork for what is expected to be the creation of a transgenic plant that will produce D-chiro inositol.

Gillaspys previous work included manipulation of inositol synthesis genes in plants to increase production of D-Chiro inositol precursors. She will be using information from the Arabidopsis plant, whose genome was totally decoded last year.

"This is the very beginning of a long process," Gillaspy said. "Were looking into how plants and animals synthesize this compound. Once we figure that out, we can look into how to make plants produce it in large quantities." Tobacco is likely to be the plant Gillaspy will try to manipulate to produce the compound because its genes are relatively easy to work with and it produces large amounts of material from which the compound can be extracted. The lack of D-chiro inositol causes Type 2 diabetes. The disease can be treated by replacing the missing inositol through medication.

"We are looking to eventually generate this compound in large quantities," Gillaspy said. "We hope the compound produced by plants will have the same properties as that produced in humans. At a deeper level, however, we are seeking to understand why the synthesis of this compound changes the signaling at the molecular level."


Contact: Stewart MacInnis
Virginia Tech

Page: 1

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
4. Researchers identify protein promoting vascular tumor growth
5. Researchers devise potent new tools to curb ivory poaching
6. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
7. Researchers ID chlorophyll-regulating gene
8. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
9. Research suggests new avenue for stopping, preventing colon cancer
10. Researchers develop fast track way to discover how cells are regulated
11. Research on carbohydrate metabolism receives historical recognition

Post Your Comments:

(Date:5/8/2019)... ... May 07, 2019 , ... ... accepted into Forbes Technology Council, an invitation-only community for world-class CIOs, CTOs, ... a full-service biopharmaceutical cold chain engineering firm that guarantees confidence in a ...
(Date:5/7/2019)... ... 2019 , ... Landsec and Spartan Bioscience today announced they ... In May, Landsec will undertake trials using Spartan’s innovative Legionella test. Spartan’s test ... corrective action within hours instead of weeks. This test, if approved, could ...
(Date:5/2/2019)... ... 01, 2019 , ... uBiome, the leader in microbial genomics, ... General Counsel, as Interim Chief Executive Officer of uBiome, effective immediately. The Company’s ... There will also be an independent investigation into uBiome’s billing practices to be ...
Breaking Biology News(10 mins):
(Date:4/15/2019)... LOVELAND, Ohio (PRWEB) , ... April 15, 2019 ... ... and oligomers, has completed construction of a $2 million bench plant expansion to ... represents an important step in the design and construction of Sirrus’ full-scale production ...
(Date:4/10/2019)... ... April 10, 2019 , ... After more than three months of ... kitchen is equipped with updated appliances and modern lighting and fixtures, and will provide ... , “We’ve seen tremendous growth in the demand for our team-building events and ...
(Date:4/9/2019)... ... 2019 , ... The American Society of Gene & Cell Therapy (ASGCT) ... a new addition to the presidential line of succession, at the 22nd Annual ... leadership team for a three-year term (2019-2021). , All five incoming members of the ...
(Date:4/8/2019)... Zealand (PRWEB) , ... April 09, 2019 , ... ... infectious disease, the innovative non-profit research center Chan Zuckerberg Biohub (CZ Biohub) has ... study of antibody repertoires is part of CZ Biohub’s efforts to establish new ...
Breaking Biology Technology:
Cached News: